Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Carcinoma of lung
|
1204 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.100 | 0.967 | 30 | 1999 | 2019 | ||||
Malignant neoplasm of lung
|
1142 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.100 | 0.967 | 30 | 1999 | 2019 | ||||
Primary malignant neoplasm of lung
|
981 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.100 | 0.967 | 30 | 1999 | 2019 | ||||
Malignant Neoplasms
|
1641 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.100 | 0.955 | 22 | 2002 | 2018 | ||||
Primary malignant neoplasm
|
1374 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.100 | 0.955 | 22 | 2002 | 2018 | ||||
Breast Carcinoma
|
2793 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.100 | 0.944 | 18 | 2002 | 2019 | ||||
Colorectal Carcinoma
|
1962 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.100 | 0.500 | 18 | 2005 | 2019 | ||||
Malignant neoplasm of breast
|
3417 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.100 | 0.944 | 18 | 2002 | 2019 | ||||
Malignant neoplasm of stomach
|
615 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.100 | 0.800 | 15 | 2001 | 2017 | ||||
Stomach Carcinoma
|
652 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.100 | 0.786 | 14 | 2001 | 2017 | ||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.100 | 0.538 | 13 | 2005 | 2015 | ||||
Bladder Neoplasm
|
281 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.070 | 0.857 | 7 | 2007 | 2014 | ||||
Carcinoma of bladder
|
309 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.070 | 0.857 | 7 | 2007 | 2014 | ||||
Liver carcinoma
|
942 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.070 | 1.000 | 7 | 2006 | 2019 | ||||
Malignant neoplasm of prostate
|
1082 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.070 | 0.857 | 7 | 2003 | 2015 | ||||
Malignant neoplasm of urinary bladder
|
316 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.070 | 0.857 | 7 | 2007 | 2014 | ||||
Prostate carcinoma
|
1168 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.070 | 0.857 | 7 | 2003 | 2015 | ||||
Alzheimer's Disease
|
1843 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.060 | 1.000 | 6 | 2007 | 2019 | ||||
Adenocarcinoma of lung (disorder)
|
563 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.050 | 1.000 | 5 | 2002 | 2012 | ||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.050 | 1.000 | 5 | 2009 | 2014 | ||||
Non-Small Cell Lung Carcinoma
|
712 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.050 | 1.000 | 5 | 2006 | 2019 | ||||
Xeroderma Pigmentosum, Complementation Group D
|
111 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.050 | 1.000 | 5 | 2006 | 2013 | ||||
Carcinogenesis
|
355 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.040 | 1.000 | 4 | 2005 | 2019 | ||||
Colon Carcinoma
|
275 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.040 | 0.500 | 4 | 2003 | 2013 | ||||
Squamous cell carcinoma of the head and neck
|
348 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.040 | 1.000 | 4 | 2006 | 2018 |